USP17L17

Across TCGA pan-cancer cohorts, USP17L17 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated USP17L17 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher USP17L17 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP17L17 expression acts as an unfavorable survival marker.

BRCA are the cancer types where USP17L17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.146	0.924	<.001	108	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

USP17L17–BRCA (OS)

Open the BRCA breakdown →